OMDA's Chief Accounting Officer Craig Gracey Sells Shares
Craig Gracey sold 6,894 shares of OMDA on June 12, 2026, in a planned transaction.
Key Points
- On June 12, 2026, OMDA's Chief Accounting Officer Craig Gracey sold 6,894 shares, valued at $120,093.
- OMDA shares traded at $17.33, with peer funds like Divisadero Street Capital significantly increasing their stakes.
- Analysts from Barclays and Citizens maintained buy ratings on OMDA, with targets up to $21.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Craig Gracey, the Chief Accounting Officer at OMDA, sold 6,894 shares of the company on June 12, 2026. The transaction was part of a planned sale, with the shares sold at an average price of $17.42, totaling approximately $120,093.
Other Institutional Activity in OMDA
Divisadero Street Capital Management significantly increased its position in OMDA, adding 5,418,118 shares to hold a total of 5,887,715 shares, valued at about $74.0 million. Revelation Capital Management maintained its position, holding 5,208,034 shares worth approximately $65.5 million. Cigna Investments made a slight adjustment, reducing its stake by just 1 share to 3,444,629 shares, valued at roughly $43.3 million. FMR LLC reduced its holdings by 1,890,124 shares, ending with 3,288,380 shares valued at $41.3 million.
Omada Health, Inc. Stock Down 26.8%
OMDA shares traded around $17.33 recently. The stock has been moving within a 52-week range from a low of $15.00 to a high of $22.00. It currently has a 50-day moving average of $18.00 and a 200-day moving average of $19.50.
$OMDA stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at Omada Health, Inc.
Along with Craig Gracey, other insiders have been active. On June 15, 2026, CFO Steven Cook sold 6,800 shares at $17.23 each. On June 12, 2026, President Wei-Li Shao sold 4,589 shares at $17.24. Earlier, on June 5, CEO Sean Duffy sold 9,450 shares, and President Shao sold 1,843 shares at $17.93. These transactions were a mix of planned and unplanned sales.
Analysts Set New Price Targets
On May 8, 2026, Barclays, Citizens, and Evercore ISI Group maintained their buy ratings for OMDA, with price targets of $20 and $21. Wells Fargo maintained a hold rating with an $18 target. Earlier, on April 14, Citizens initiated coverage with a buy rating and an $18 target.
Bottom Line
Craig Gracey's recent planned sale of OMDA shares is part of regular insider activity. Investors often watch insider transactions for insights, though these actions don't necessarily signal future stock performance. Peer fund movements and analyst ratings also provide context for OMDA's market position.
Get Omada Health, Inc. alerts
New 13F filings, insider trades, and analyst moves on $OMDA, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.